News

Ancor joined Sentinel Capital and Yukon Capital to complete the transaction. Ancor Capital Partners managing partner J Randall Keene said WellSpring represents the 15th acquisition of a healthcare

The study demonstrated that the combination of two oral direct acting anti hepatitis C virus (HCV) compounds (the protease inhibitor BI 201335 and the polymerase inhibitor BI 207127,

Adeona’s wellZin is oral zinc lozenge used to reduce the duration and symptoms of the common cold. The pharma company intends to commercialize the lozenge that contains 13.3

The university is set to enter a five-year contract with the Anticonvulsant Drug Development Program within the National Institutes of Health, therepublic.com reported, citing The Associated Press. Utah

The company intends to increase L-Lysine production capacity by 150 kilo metric tonne (KMT), L-Threonine by 80 KMT, and L-Tryptophan by 7 KMT. Feed-use amino acid products will

AM-831 drug combines muscarinic m1 partial agonism with both dopamine D2 and serotonin 5-HT2A antagonism. The Phase I study is intended to evaluate the safety, tolerability and pharmacokinetics

Plenadren, an oral once daily tablet, is a dual release hydrocortisone replacement therapy. The move follows the satisfactory opinion adopted by the Committee for Medicinal Products for Human

New investors include GE, BioMed Ventures and Henri Termeer, former Chairman and CEO of Genzyme Corporation. According to the company, the financing will be used to continue the

Cimzia is a PEGylated anti-TNF (Tumor Necrosis Factor), having high affinity for human TNF-alpha, selectively neutralizing the pathophysiological effects of TNF-alpha. The data suggested that disease activity response